Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyalase vs Midazolam Hydrodissection for Carpal Tunnel Syndrome
NCT05344495Phase 1Unknown
- Sponsor
- Minia University
- Start
- Jan 2022
- Primary completion
- Jul 2022
- Modality
- Therapeutic Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in carpal tunnel syndrome (CTS) comparing Hyalase Group with Midazolam Group (2 arms). Primary endpoint: Visual Analog Scale (VAS) for Pain at 6 months. Status: unknown.
02
Drugs
hyaluronidasemidazolam
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT05344495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05344495.